The autoclaving and re-implantation of an infected prosthesis as a spacer during resection knee arthroplasty: a systematic review.


Journal

Musculoskeletal surgery
ISSN: 2035-5114
Titre abrégé: Musculoskelet Surg
Pays: Italy
ID NLM: 101498346

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 31 01 2021
accepted: 12 07 2021
pubmed: 30 7 2021
medline: 27 5 2022
entrez: 29 7 2021
Statut: ppublish

Résumé

Hofmann et al., in 1995, first described an articulating spacer made by cleaning and autoclaving the original femoral component, which is then re-implanted with a new tibial polyethylene. This systematic review aims to assess the state of existing evidence on the intraoperative autoclaving and re-use of an infected prosthesis, as a spacer, during a two-stage revision following Periprosthetic Joint Infections (PJI). A systematic review was conducted with methods described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. OVID-MEDLINE Fourteen studies were included in this systematic review: two prospective case series; six retrospective comparative studies and six retrospective case series. The reviewed studies included 567 patients (571 knees): 394 patients treated with autoclaved components and 173 with a spacer made of new components. The cumulative re-infection rate in patients treated with re-used autoclaved components was 13.7% (54 re-infections in 394 patients), whereas in control patients the re-infection rate was 13.3% (23 re-infections in 173 patients). The final Range of Movement in patients treated using the autoclaved components as a spacer, compared with patients receiving static spacers, was significantly higher in three out of four comparative studies. There is a moderate level of evidence that the intraoperative autoclaving and re-use of an infected prosthesis as a spacer, during a knee resection arthroplasty, is an effective procedure in the management of knee PJI.

Sections du résumé

BACKGROUND BACKGROUND
Hofmann et al., in 1995, first described an articulating spacer made by cleaning and autoclaving the original femoral component, which is then re-implanted with a new tibial polyethylene. This systematic review aims to assess the state of existing evidence on the intraoperative autoclaving and re-use of an infected prosthesis, as a spacer, during a two-stage revision following Periprosthetic Joint Infections (PJI).
METHODS METHODS
A systematic review was conducted with methods described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. OVID-MEDLINE
RESULTS RESULTS
Fourteen studies were included in this systematic review: two prospective case series; six retrospective comparative studies and six retrospective case series. The reviewed studies included 567 patients (571 knees): 394 patients treated with autoclaved components and 173 with a spacer made of new components. The cumulative re-infection rate in patients treated with re-used autoclaved components was 13.7% (54 re-infections in 394 patients), whereas in control patients the re-infection rate was 13.3% (23 re-infections in 173 patients). The final Range of Movement in patients treated using the autoclaved components as a spacer, compared with patients receiving static spacers, was significantly higher in three out of four comparative studies.
CONCLUSION CONCLUSIONS
There is a moderate level of evidence that the intraoperative autoclaving and re-use of an infected prosthesis as a spacer, during a knee resection arthroplasty, is an effective procedure in the management of knee PJI.

Identifiants

pubmed: 34322843
doi: 10.1007/s12306-021-00722-x
pii: 10.1007/s12306-021-00722-x
pmc: PMC9130160
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-125

Informations de copyright

© 2021. The Author(s).

Références

J Arthroplasty. 2010 Dec;25(8):1175-81
pubmed: 20870384
J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6 Suppl. 1):9-13
pubmed: 30644275
Indian J Orthop. 2016 Mar-Apr;50(2):146-53
pubmed: 27053803
J Arthroplasty. 2017 Jul;32(7):2047-2050
pubmed: 28343826
J Bone Joint Surg Am. 2005 Oct;87(10):2335-48
pubmed: 16224857
Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):43-50
pubmed: 30977870
J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1081-1086
pubmed: 29254318
Clin Orthop Relat Res. 2005 Jan;(430):125-31
pubmed: 15662313
Musculoskelet Surg. 2020 Apr;104(1):25-35
pubmed: 30879231
Musculoskelet Surg. 2020 Aug;104(2):195-200
pubmed: 31147964
Clin Orthop Relat Res. 2012 Jan;470(1):228-35
pubmed: 21863391
EFORT Open Rev. 2017 Mar 13;1(7):275-278
pubmed: 28461959
Clin Orthop Surg. 2015 Sep;7(3):310-7
pubmed: 26330952
J Bone Joint Surg Am. 2009 Jan;91(1):128-33
pubmed: 19122087
Am J Infect Control. 2010 Nov;38(9):711-7
pubmed: 21034980
Musculoskelet Surg. 2020 Aug;104(2):135-143
pubmed: 31643045
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
Clin Orthop Relat Res. 2010 Jan;468(1):45-51
pubmed: 19554385
J Arthroplasty. 2018 Aug;33(8):2595-2604
pubmed: 29691170
Injury. 2018 Dec;49 Suppl 4:S58-S62
pubmed: 30526950
Clin Epidemiol. 2012;4:57-73
pubmed: 22500127
PLoS One. 2016 Mar 11;11(3):e0151537
pubmed: 26967645
J Arthroplasty. 2017 Jul;32(7):2039
pubmed: 28390889
Knee Surg Relat Res. 2013 Dec;25(4):180-5
pubmed: 24368995
Clin Orthop Surg. 2018 Dec;10(4):427-432
pubmed: 30505410
J Arthroplasty. 2016 Jan;31(1):245-9
pubmed: 26282497
J Knee Surg. 2021 Aug;34(10):1092-1097
pubmed: 32131100
Oper Orthop Traumatol. 2006 Mar;18(1):66-87
pubmed: 16534562
J Arthroplasty. 2006 Dec;21(8):1163-8
pubmed: 17162176
J Arthroplasty. 2009 Jun;24(4):631-5
pubmed: 18534535
PLoS One. 2015 Sep 25;10(9):e0139166
pubmed: 26407003
Musculoskelet Surg. 2021 Aug;105(2):195-200
pubmed: 31993973
Clin Orthop Relat Res. 1995 Dec;(321):45-54
pubmed: 7497685
Musculoskelet Surg. 2020 Apr;104(1):87-92
pubmed: 31054080
J Arthroplasty. 2007 Oct;22(7):1060-6
pubmed: 17920482
Clin Orthop Relat Res. 2002 Nov;(404):132-8
pubmed: 12439251
J Arthroplasty. 2005 Jun;20(4 Suppl 2):33-6
pubmed: 15991126
Int Orthop. 2006 Aug;30(4):257-61
pubmed: 16565839
Knee. 2017 Oct;24(5):1175-1181
pubmed: 28797875
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508

Auteurs

Antonio Spinarelli (A)

Neuroscience and Sense Organs, Orthopaedic and Trauma UnitDepartment of Basic Medical SciencesSchool of Medicine, University of Bari Aldo Moro, AOU Consorziale "Policlinico", Piazza Giulio Cesare 11, 700124, Bari, Italy.

Davide Bizzoca (D)

Neuroscience and Sense Organs, Orthopaedic and Trauma UnitDepartment of Basic Medical SciencesSchool of Medicine, University of Bari Aldo Moro, AOU Consorziale "Policlinico", Piazza Giulio Cesare 11, 700124, Bari, Italy. da.bizzoca@gmail.com.
PhD Course in Public Health, Clinical Medicine, and Oncology, University of Bari "Aldo Moro, Piazza Giulio Cesare 11, 70100, Bari, Italy. da.bizzoca@gmail.com.

Lorenzo Moretti (L)

Neuroscience and Sense Organs, Orthopaedic and Trauma UnitDepartment of Basic Medical SciencesSchool of Medicine, University of Bari Aldo Moro, AOU Consorziale "Policlinico", Piazza Giulio Cesare 11, 700124, Bari, Italy.

Giovanni Vicenti (G)

Neuroscience and Sense Organs, Orthopaedic and Trauma UnitDepartment of Basic Medical SciencesSchool of Medicine, University of Bari Aldo Moro, AOU Consorziale "Policlinico", Piazza Giulio Cesare 11, 700124, Bari, Italy.

Raffaele Garofalo (R)

Upper Limb Unit. "F Miulli" Hospital, Acquaviva Delle Fonti, Bari, Italy.

Biagio Moretti (B)

Neuroscience and Sense Organs, Orthopaedic and Trauma UnitDepartment of Basic Medical SciencesSchool of Medicine, University of Bari Aldo Moro, AOU Consorziale "Policlinico", Piazza Giulio Cesare 11, 700124, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH